3 |Drug Literature Evaluation Flashcards

1
Q

Pharmacists need to ___________ locate, ____________ analyze, and ______________ communicate data from the primary literature in daily activities of patient care and medication use process.

A

efficiently locate, critically analyze, and effectively communicate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Premiere study design to measure and quantify differences in the effect of the intervention and control

A

Controlled Clinical Trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Consists of an investigational (intervention) group being directly compared to a control group

A

Controlled Clinical Trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Example of control groups include standard therapy, placebo

A

Controlled Clinical Trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

most robust method to measure and quantify differences in effects between a therapy under study and the control group

A

Controlled Clinical Trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Subjected to experimental treatment

A

Experimental group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Subjected to standard treatment

A

Standard group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Reflective of the work, unbiased, specific, and concise but not too general or detailed

A

Title

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Number of words for title to be considered concise

A

usually ≲ 10 words

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T/F: Title pertains to a declarative sentences that tends to overemphasize conclusions are not preferred

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

should be identified in the title if performed

A

RCT (Randomized controlled trial)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T/F: Title should include key words that are both sensitive and specific

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Characteristic of a title that eases the task of locating the appropriate articles

A

sensitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Characteristic of a title that exclude those not being searched for

A

specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is wrong with this title?

Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma.

A

word “improved” assumes conclusion without readers having fully-read the entire work

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

A concise overview of the study or a synopsis of the significant principles of the article

A

Abstract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Abstract includes information addressing the article’s ____________, ___________, _____________, _________________.

A

objective, methods, results, conclusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Abstract should be ____________, ________________, and ______________ in wording selection

A

thorough, complete, and unbiased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Usually composed of 1-2 sentences for the introduction about the topic, followed by the objectives, methods, results, and conclusions

A

Abstract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

The introduction tackles 2 things

A
  1. study rationale
  2. study purpose/objective
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

the set of reasons a researcher uses to justify the need to conduct another research on the chosen topic

A

study rationale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

statement that helps readers assess the importance of the
study relative to individual values

A

study purpose/objective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

should include immediate and more extensive, eventual purpose

A

study purpose/objective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
T/F: Research hypothesis and null hypothesis are formulated before the objectives
False (after the objectives)
26
states the difference in the therapy under investigation and control
Research hypothesis
27
states no difference between the two groups
Null hypothesis
28
may be missing in the introduction section and may be considered a deficiency but does not mean that the paper contains unreliable information
hypothesis
29
Design of the study is essential for the results to be valid
Methods
30
Includes types of subjects enrolled, the comparative therapy description, outcome measures, and statistics
Methods
31
Two (2) types of validity of Clinical Trials
1. Internal validity 2. External validity
32
Quality of the study design
Internal validity
33
Ability to apply results to practice
External validity
34
Strong design should translate into reliable results
Application of Internal validity
35
Study results meaningful to practitioners and can be used for patient care
Application of External validity
36
Used to check whether a method can be applied to other practice
External Validity
37
Used to check whether a study can produce good results
Internal Validity
38
T/F: Study questions does not dictate study design
False
39
prospectively measures a difference in effect between two or more therapies
Controlled clinical trial
40
In CCTs, groups are __________ and _______________________ with the except for the treatments under observation
similar and treated identically
41
subjects in the study are assigned to one of the groups and monitored
Parallel design
42
the most rigorous method of establishing a cause-and-effect relationship between treatment and outcome
Controlled clinical trial
43
_________ the cause while _________ is the effect
treatment (cause); outcome (effect)
44
compared to the among groups
treatment effect
45
T/F: The magnitude of the difference in the outcome is not usually estimated.
False (outcome can be estimated)
46
should be extrapolated to the patient type enrolled in the study
results of a controlled clinical trial
47
Readers must be aware of the limitations of surrogate endpoints and subgroup analysis results
Patient Inclusion/Exclusion Criteria (Methods)
48
a study measurement (lab value or physical assessment) that serves as a substitute marker for an actual clinical outcome (LDL levels for cardiovascular events)
Surrogate endpoint
49
lists subject demographics that must be present for the subject to be enrolled in the trial
Inclusion criteria
50
characteristics that prevent a subject from enrollment in the trial or necessitate withdrawal from the study
Exclusion criteria
51
CONDOR (Celecoxib versus Omeprazole and Diclofenac in patients with Osteoarthritis and rheumatoid arthritis) trial is an example of what?
Patient Inclusion/Exclusion Criteria (Methods)
52
Selection bias may be present
Patient Inclusion/Exclusion Criteria (Methods)
53
T/F: Selection bias occurs after subjects meet the inclusion criteria but are disqualified from taking part in the study
True
54
A common form in the run-in phase (Lead-in phase)
Selection bias
55
Investigators prevent them from being enrolled because they may alter the results either positively or negatively
Selection bias
56
Run-in phase is also known as
Lead-in phase
57
2-4 weeks before being officially enrolled
Run-in phase (Lead-in phase)
58
Can identify subjects who may or may not adhere to the therapy regimen, experience side effects from the therapy, or did not meet pre-specified criteria
Run-in phase (Lead-in phase)
59
excluded from participating even if they met the original inclusion criteria
Run-in phase (Lead-in phase)
60
Produces a bias by selecting a group who do not entirely represent the population
Run-in phase (Lead-in phase)
61
consists of the therapy under investigation (medication or procedure)
Intervention group
62
Control group consists of either of the three (3) considerations
1. no therapy (placebo) 2. another therapy (active control) 3. existing data (historical data)
63
These two are supposed to be as similar as possible in all respects (average age, number of male/female, medication use, disease states) other than the treatment received
Intervention & control group
64
committee charged with ensuring the participants are protected and not exposed to unnecessary harm or unethical medical procedures
Institutional Review Board (IRB)
65
participant is presented with a document
Informed consent form
66
Informed consent form is used to notify participants about ?
1. study procedures 2. the rights and responsibilities of the participant 3. the risks, benefits, compensation, and voluntary participation 4. right to withdraw without penalty
67
ensures humane treatment for animal models used in the study
Institutional Animal Care and Use Committee (IACUC)
68
These committees are sometimes used to substitute for IRB
Review Ethics Committee (REC) or Ethics Review Committee (ERC)
69
A technique in which subjects, investigators, or both are unaware of who is in the intervention or control group
Blinding (Methods)
70
The purpose of blinding is to_________ the influence of bias on measuring a difference in effect between the intervention and control
reduce
71
Four types of blinding
1. No blinding (open-label) 2. Single 3. Double 4. Triple
72
Investigators and subjects are aware of the assignment to the intervention or control
No blinding (open-label)
73
Either investigators or subjects, but not both, are aware of the assignment
Single
74
Both investigators and subjects are unaware of the assignment
Double
75
Like double blinding, both investigators and subjects unaware
Triple
76
data interpretation personnel is unaware of subject assignment as well
Triple
77
All persons in a clinical trial who have an equal chance to be in the intervention(treatment) or control group
Randomization (Methods)
78
T/F: Using randomization method, the results are less dependable than nonrandomized trials
False (more dependable)
79
one effect caused by the intervention and control
Primary endpoint
80
Example includes BMI measurement as an endpoint for assessing obesity
Primary endpoint
81
routine and useful measure; not considered to be the primary purpose of the study
Secondary endpoint
82
Example includes
weight and height measurements for computing BMI
83
T/F: The primary endpoint should be appropriate for the study purpose and measured using correct techniques and methods.
True
84
a combination of endpoint measures into one primary endpoint
Composite endpoint
85
Composite endpoint consists of clinical outcomes ___________________ to morbidity and mortality as opposed to a pharmacological action (reduction in any incidence of stroke/MI/CV-related death vs. lowering cholesterol levels
directly related
86
aims to measure the overall effect of therapy
Composite endpoint
87
include actual data collection period, follow-up, and monitoring of adherence
Data Gathering
88
Two considerations for data gathering
1. study should be conducted for an appropriate duration 2. data need to be consistently collected throughout the entire trial
89
Data gathering (Methods) Monitoring of the trial results at predetermined intervals is _____________________ the trial.
essential throughout
90
Four things that should be established before data gathering proceeds:
1. protocol for discontinuing the clinical trial earlier than scheduled 2. data collection methods 3. competency of trial personnels 4. availability of data collection materials
91
92